FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
HIV Infections
Interventions
DRUG

Intermitent Dosing

"Intermittent dosing treatment is the maintenance of the 5/2 schedule, where the regimen, 300 mg tenofovir td, 600 mg efavirenz, 200 mg emtricitabine is dosed for 5 consecutive days - typically Monday through Friday - followed by two days off of medication, 300 mg tenofovir td, 600 mg efavirenz, 200 mg emtricitabine. ."

Trial Locations (7)

20009

Whitman-Walker Clinic, Washington D.C.

20037

CARE-ID, Washington D.C.

32803

Orlando Immunology Center, Orlando

32960

Treasure Chest Infectious Disease, Vero Beach

33133

Steinhart Medical Associates, Miami

02215

Community Research Initiative of New England - Boston, Boston

01107

Community Research Initiative of New England - West, Springfield

All Listed Sponsors
collaborator

The Campbell Foundation

OTHER

lead

Community Research Initiative of New England

OTHER

NCT00414635 - FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment | Biotech Hunter | Biotech Hunter